StockData
Baxter International Inc logo

Baxter International Inc (BAX) stock

BAXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 9/306% above fair value
$25.76+0.22 (+0.86%)

Close on Nov 17, 2026Market cap $13.33BP/E –Yield 2.02%

Baxter International operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Baxter International's operating cash flow for the twelve months ending Sep 30, 2026 was $1.64B, up 119.0% year over year. For fiscal 2025 it was $845.00M, down 17.1% from the year before. Over ten years it grew -7.1% a year on average. The highest annual figure on record is $3.22B in fiscal 2014.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$845.00M-17.1%
FY2024Dec 31, 2024$1.02B-41.0%
FY2023Dec 31, 2023$1.73B+42.5%
FY2022Dec 31, 2022$1.21B-45.5%
FY2021Dec 31, 2021$2.22B+19.0%
FY2020Dec 31, 2020$1.87B-11.2%
FY2019Dec 31, 2019$2.10B+4.3%
FY2018Dec 31, 2018$2.02B+17.7%
FY2017Dec 31, 2017$1.71B+3.6%
FY2016Dec 31, 2016$1.65B-6.6%
FY2015Dec 31, 2015$1.77B-44.9%
FY2014Dec 31, 2014$3.22B+0.5%
FY2013Dec 31, 2013$3.20B+3.0%
FY2012Dec 31, 2012$3.11B+10.3%
FY2011Dec 31, 2011$2.82B-6.2%
FY2010Dec 31, 2010$3.00B+3.2%
FY2009Dec 31, 2009$2.91B+15.7%
FY2008Dec 31, 2008$2.52B+9.1%
FY2007Dec 31, 2007$2.31B–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$558.00M+135.4%
Q2 FY2026Jun 30, 2026$285.00M+31.3%
Q1 FY2026Mar 31, 2026$213.00M–
Q4 FY2025Dec 31, 2025$584.00M+19.7%
Q3 FY2025Sep 30, 2025$237.00M-6.3%
Q2 FY2025Jun 30, 2025$217.00M+88.7%
Q1 FY2025Mar 31, 2025-$193.00M-218.4%
Q4 FY2024Dec 31, 2024$488.00M-8.1%
Q3 FY2024Sep 30, 2024$253.00M-30.7%
Q2 FY2024Jun 30, 2024$115.00M-67.2%
Q1 FY2024Mar 31, 2024$163.00M-66.0%
Q4 FY2023Dec 31, 2023$531.00M+21.0%
Q3 FY2023Sep 30, 2023$365.00M+25.9%
Q2 FY2023Jun 30, 2023$351.00M+28.1%
Q1 FY2023Mar 31, 2023$479.00M+130.3%
Q4 FY2022Dec 31, 2022$439.00M-36.7%
Q3 FY2022Sep 30, 2022$290.00M-57.0%
Q2 FY2022Jun 30, 2022$274.00M-42.6%
Q1 FY2022Mar 31, 2022$208.00M-44.8%
Q4 FY2021Dec 31, 2021$693.00M-2.7%
Q3 FY2021Sep 30, 2021$675.00M+32.4%
Q2 FY2021Jun 30, 2021$477.00M+27.5%
Q1 FY2021Mar 31, 2021$377.00M+38.6%
Q4 FY2020Dec 31, 2020$712.00M-14.1%
Q3 FY2020Sep 30, 2020$510.00M-27.2%
Q2 FY2020Jun 30, 2020$374.00M-16.1%
Q1 FY2020Mar 31, 2020$272.00M+112.5%
Q4 FY2019Dec 31, 2019$829.00M+16.9%
Q3 FY2019Sep 30, 2019$701.00M+47.3%
Q2 FY2019Jun 30, 2019$446.00M+10.9%
Q1 FY2019Mar 31, 2019$128.00M-70.2%
Q4 FY2018Dec 31, 2018$709.00M+81.3%
Q3 FY2018Sep 30, 2018$476.00M-21.3%
Q2 FY2018Jun 30, 2018$402.00M-24.0%
Q1 FY2018Mar 31, 2018$430.00M+127.5%
Q4 FY2017Dec 31, 2017$391.00M-45.2%
Q3 FY2017Sep 30, 2017$605.00M–
Q2 FY2017Jun 30, 2017$529.00M–
Q1 FY2017Mar 31, 2017$189.00M–
Q4 FY2016Dec 31, 2016$713.00M–

More Baxter International figures

See a number that looks wrong?